Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe

Eurosurveillance

Volumn 17, Issue 4, 2012, Pages

  Mereckiene, J ^a,b   Cotter, S ^a,b   Weber, J T ^c   Nicoll, A ^d   D'Ancona, F ^b,e   Lopalco, P L ^d   Johansen, K ^d   Wasley, A M ^f   Jorgensen, P ^f   Levy Bruhl D ^b,g   Giambi, C ^b,e   Stefanoff, P ^b,h   Dematte, L ^b,i   O'Flanagan, D ^a,b  

^a HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

^b Vaccine European New Integrated Collaboration Effort (VENICE) Project   (Italy)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g INSTITUT DE VEILLE SANITAIRE   (France)

^h NATIONAL MEDICINES INSTITUTE   (Poland)

ⁱ CINECA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANTGRIP; FLUVAL P; INFLUENZA VACCINE; PANVAXH1N1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; DRUG MONITORING; EUROPE; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; IMMUNOMODULATION; INFANT; INFLUENZA A (H1N1); PREGNANT WOMAN; VACCINATION;

EID: 84856297641     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.17.04.20064-en     Document Type: Article

References (44)

1. World Health Organization (WHO). Clinical management of human infection with new influenza A (H1N1) virus: initial guidance. Geneva: WHO; 21 May 2009. Available from: http://www.who.int/csr/resources/publications/swineflu/clinical_managementH1N1_21_May_2009.pdf.
2. Council of the European Union. Communication from the Commission to the Council on the transitional prolongation and extension of the mandate of the Health Security Committee in view of a future general revision of the structures dealing with health threats at EU level. Brussels: Council of the European Union. 5 Feb 2007. Available from: http://register.consilium.europa.eu/pdf/en/07/st05/st05862.en07.pdf.
3. World Health Organization (WHO). Strategic Advisory Group of Experts on Immunization -report of the extraordinarymeeting on the influenzaA (H1N1) 2009 pandemic, 7 July 2009. Wkly Epidemiol Rec. 2009;84(30):301-4.
4. European Centre for Disease Prevention and Control (ECDC). ECDC Interim Guidance. Use of specific pandemic influenza vaccines during the H1N1 2009 pandemic. Stockholm: ECDC. Aug 2009. Available from: http://www.ecdc.europa.eu/en/publications/Publications/0908_GUI_Pandemic_Influenza_Vaccines_during_the_H1N1_2009_Pandemic.pdf.
5. European Union Health Security Committee (HSC)/Early Warning and Response System (EWRS). HSC/EWRS Statment on Influenza A(H1N1) 2009: target and priority groups forvaccination. 25 Aug 2009. http://ec.europa.eu/health/ph_threats/com/Influenza/docs/HSC_EWRS_statement_en.pdf.
6. Johansen K, Nicoll A, Ciancio BC, Kramarz P. Pandemic influenza A(H1N1) 2009 vaccines in the European Union. Euro Surveill. 2009;14(41):pii=19361. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19361.
7. European Centre for Disease Prevention and Control (ECDC). Guidance. Priority risk groups for influenza vaccination. Stockholm: ECDC. Aug 2008. Available from: http://www.ecdc.europa.eu/en/publications/Publications/0808_GUI_Priority_Risk_Groups_for_Influenza_Vaccination.pdf.
8. Fleming DM, Elliot AJ. Estimating the risk population in relation to influenza vaccination policy. Vaccine. 2006;24(20):4378-85.
9. European Commission, Crisis Management Research and Trainig, Health Protection Agency. Assessment Report on EU-wide Pandemic Vaccine Strategies. 25 Aug 2010. Available from: http://ec.europa.eu/health/communicable_diseases/docs/assessment_vaccine_en.pdf.
10. European Medicines Agency (EMA). Medicines authorised during pandemic. London: EMA. [Accessed 20 Aug 2011]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000251.jsp&murl=menus/special_topics/special_topics.jsp&mid=WC0b01ac05801db932.
11. Vaccine European New Integrated Collaboration Effort (VENICE). Pandemic A(H1N1)2009 influenza vaccination survey, influenza season 2009/2010. VENICE. 2011. Restricted-access document.
12. Swedish Medical Products Agency (Läkemedelsverket, MPA). A Swedish registry based cohort study provides strengthened evidence of an association between vaccination with Pandemrix and narcolepsy in children and adolescents. Uppsala: MPA; 29 Mar 2011. Available from: http://www.lakemedelsverket.se/english/All-news/NYHETER-2011/A-Swedish-registry-based-cohort-study-provides-strengthened-evidence-of-an-association-between-vaccination-with-Pandemrix-and-narcolepsy-in-children-and-adolescents-/.
13. Mereckiene J, Cotter S, Nicoll A, Lévy-Bruhl D, Ferro A, Tridente G, et al. National Seasonal Influenza Vaccination Survey in Europe, 2008. Euro Surveill. 2008;13(43):pii=19017. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19017.
14. Centers for Disease Control and Prevention (CDC). Intensive- Care Patients With Severe Novel Influenza A (H1N1) Virus Infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep. 2009;58(27):749-52.
15. Louie JK, Acosta M, Samuel MC, Schechter R, Vugia DJ, Harriman K, et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 2011;52(3):301-12.
16. World Health Organization (WHO). Safety of pandemic (H1N1) 2009 vaccines. Geneva: WHO; 30 Oct 2009. Available from: http://www.who.int/csr/disease/swineflu/frequently_asked_questions/vaccine_preparedness/safety_approval/en/
17. Hewagama S, Walker SP, Stuart RL, Gordon C, Johnson PD, Friedman ND, et al. 2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia. Clin Infect Dis. 2010;50(5):686-90.
18. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet;374(9688):451-8.
19. White SW, Petersen RW, Quinlivan JA. Pandemic (H1N1) 2009 influenza vaccine uptake in pregnant women entering the 2010 influenza season in Western Australia. Med J Aust. 20104;193(7):405-7.
20. European Centre for Disease Prevention and Control (ECDC). Safety experience of influenza vaccination in pregnant women in the US over a 20-year period. Stockholm: ECDC. 5 Nov 2010. Available from: http://ecdc.europa.eu/en/activities/sciadvice/Lists/ECDC%20Reviews/ECDC_DispForm.aspx?List=512ff74f%2D77d4%2D4ad8%2Db6d6%2Dbf0f23083f30&ID=972.
21. Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359(15):1555-64.
22. Frank AL, Taber LH, Wells CR, Wells JM, Glezen WP, Paredes A. Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis. 1981;144(5):433-41.
23. Glezen WP, Couch RB. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med. 1978;298(11):587-92.
24. Plotkin SA, Orenstein WA, Offit PA. Inactivated influenza vaccines. Vaccines. Fifth edition. Elsevier-Saunders. 2008. p. 259-90.
25. Mereckiene J, Cotter S, Weber JT, Nicoll A, Lévy-Bruhl D, Ferro A, et al. Low coverage of seasonal influenza vaccination in the elderly in many European countries. Euro Surveill. 2008;13(41):pii=19001. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19001.
26. Pebody RG, McLean E, Zhao H, Cleary P, Bracebridge S, Foster K, et al. Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill. 2010;15(20):pii=19571. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19571.
27. Carman WF, Elder AG, Wallace LA, McAulay K, Walker A, Murray GD, et al. Effects of influenza vaccination of healthcare workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet. 2000;355(9198):93-7.
28. Hayward AC, Harling R, Wetten S, Johnson AM, Munro S, Smedley J, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ. 2006;333(7581):1241.
29. Saxen H, Virtanen M. Randomized, placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of healthcare workers. Pediatr Infect Dis J. 1999;18(9):779-83.
30. Wilde JA, McMillan JA, Serwint J, Butta J, O'Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA. 1999;281(10):908-13.
31. Helferty M, Vachon J, Tarasuk J, Rodin R, Spika J, Pelletier L. Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009. CMAJ. 2010;182(18):1981-7.
32. Nicolay N, Callaghan MA, Domegan LM, Oza AN, Marsh BJ, Flanagan PC, et al. Epidemiology, clinical characteristics and resource implications of pandemic (H1N1) 2009 in intensive care units in Ireland. Crit Care Resusc. 2010;12(4):255-61.
33. Abraham T. The price of poor pandemic communication. BMJ. 2010;340:c2952.
34. Jakab Z. Pandemic 2009-10. ECDC's future look and risk assessment. Briefing to the Swedish Presidency Informal Council, Jönköping, Sweden. Speaking notes. Stockholm: ECDC. 5 Jul 2009. Available from: http://www.ecdc.europa.eu/en/press/news/Documents/0907_ZJ_Pandemic_2009_2010_Future_Look_and_Risk_Assessment.pdf.
35. Skowronski DM, Janjua NZ, De Serres G, Hottes TS, Dickinson JA, Crowcroft N, et al. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ. 2011;342. c7297.
36. Gilmour H, Hofmann N. H1N1 vaccination. Health Rep. 2010 Dec;21(4):63-9.
37. Centers for Disease Control and Prevention (CDC). Final estimates for 2009-10 Seasonal Influenza and Influenza A (H1N1) 2009 Monovalent Vaccination Coverage - United States, August 2009 through May, 2010. Atlanta: CDC. 13 May 2011. Available from: http://www.cdc.gov/flu/professionals/vaccination/coverage_0910estimates.htm.
38. SteelFisher GK, Blendon RJ, Bekheit MM, Lubell K. The public's response to the 2009 H1N1 influenza pandemic. N Engl J Med. 2010;362(22):e65.
39. Rubin GJ, Potts HW, Michie S. The impact of communications about swine flu (influenza A H1N1v) on public responses to the outbreak: results from 36 national telephone surveys in the UK. Health Technol Assess. 2010;14(34):183-266.
40. European Medicines Agency (EMA). Summary of product characteristics. London: EMA. [Accessed 20 Aug 2011]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000832/WC500038121.pdf.
41. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche- Aranda C, Hernandez M, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med. 2009;361(7):674-9.
42. World Health Organization (WHO). Implementation of the International Health Regulations (2005). Report of the review committee on the functioning of the International Health Regulations (2005) in relation to pandemic (H1N1)2009. Geneva: WHO. 5 May 2011. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA64/A64_10-en.pdf.
43. European Commission. Proposal for a Council recommendation on seasonal influenza vaccination. Brussels: European Commission. 13 Jul 2009. Available from: http://ec.europa.eu/health/ph_threats/com/Influenza/docs/seasonflu_rec2009_en.pdf.
44. Council of the European Union. Council recommendation of 22 December 2009 on seasonal influenza vaccination (2009/1019/ EU). Luxembourg: Official Journal of the European Union. 29 Dec 2009. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:348:0071:0072:EN:PDF.